Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2025 is 3.36% vs 0.57% in Jun 2024
Consolidate Net Profit
YoY Growth in quarter ended Jun 2025 is -84.55% vs -30.12% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2025 is -80.93% vs -13.44% in Jun 2024
Interest
YoY Growth in quarter ended Jun 2025 is 100.00% vs 25.00% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024
Compare Quarterly Results Of Kaken Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 4.56% vs -26.70% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 3.36% vs 0.57% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 105.18% vs -206.97% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -84.55% vs -30.12% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 117.31% vs -158.12% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -80.93% vs -13.44% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 11.11% vs 28.57% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 100.00% vs 25.00% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024






